Delivery Order SPE2DB22D1106-SPE2DB25FEPT4

Award Date 5/22/25
Potential Completion Date 5/23/25
Potential Value $1.5K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of PREGNYL 10,000 UNIT VIALS to the Defense Logistics Agency (DLA). The $2,002.37 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical, running through November 2026. The IDC enables efficient...
This federal contract award, valued at $3,867.02, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of PREGNYL 10,000 UNIT VIALS, a pharmaceutical product, with a completion date of February 10, 2025. The contract is a Delivery Order with a Firm Fixed Price pricing type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds...
This federal contract award, valued at $4,177.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,254,286 units of the drug Pregnyl 10,000 unit vials, with a completion date of February 13, 2025. The contract is a Delivery Order under a Firm Fixed Price pricing type, and does not have a set-aside designation, indicating open competition....
This federal contract award, valued at $3,240.62, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 10,000 unit vials of the medication Pregnyl, a hormone treatment. This is a firm fixed-price delivery order contract with an ultimate completion date of April 16, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,373.20 firm fixed-price contract is for the delivery of 10,000 unit vials of the medication Pregnyl, with a completion date of December 6, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,209.00, is for the supply of 10,000 unit vials of the medication Pregnyl. The contract is a firm fixed-price delivery order and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,388.96 firm fixed-price contract is for the delivery of 4,565,131,503 vials of Pregnyl 10,000 unit medication. The contract has a completion date of July 15, 2024 and was awarded on July 12, 2024. There is no set-aside designation for this contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award, with an identifier of SPE2DB22D1106|SPE2DB25FEGU0, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567843197 units of Pregnyl 10,000 unit vials, with an ultimate completion date of April 9, 2025 and a ceiling value of $1,813.50. The contract is a Delivery Order with a Firm Fixed Price pricing type, and is not designated with...
This federal contract award, valued at $5,134.39, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for 10,000 units of chorionic gonad, a medical product. The contract is not set-aside and is a firm fixed-price arrangement with an ultimate completion date of April 28, 2025. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award is a delivery order valued at $1,454.10 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of various pharmaceutical products and medical supplies, including prescription medications, medical devices, specialty pharmaceuticals, vaccines, and other healthcare-related items. The contract does not have a set-aside designation, indicating open...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEPT4
    Delivery Order

This federal contract award is a delivery order with a firm fixed price valued at $1,450.80 awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of PREGNYL 10,000 UNIT VIALS and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a critical supplier of medical and pharmaceutical products to federal agencies, including the Defense Health Agency and U.S. Coast Guard, through a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. This IDC provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026, enabling the company to supply a vast range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.

Generated 8/21/25, 9:43 AM